Introduction {#s1}
============

Sleep and headache are widely related from a clinical point of view. The biological relationship between sleep and pain processing is not fully understood yet. Presently, a unique hypothesis about the mutual inter-relationship between sleep and primary headaches cannot be presented. In this picture, we can assume that various mechanisms may be responsible for the different clinical features observed in association with headache and sleep ([@B1]). However, the connection between sleep disorders and primary headaches is clinically relevant since both conditions tend to establish mutual interrelationships that influence each other ([@B2]--[@B4]). In this context, the clinical observation raises questions regarding the pathogenesis of these disorders, involving pivotal cerebral structures (i.e., thalamus, hypothalamus, and some brainstem nuclei) and specific neurochemical pathways both in pain perception and sleep regulation.

The hypothalamus is crucial in both headache pathogenesis and sleep-wake cycle regulation because of its connection with the anti-nociceptive system \[i.e., medulla oblongata, serotoninergic raphe nucleus, noradrenergic locus coeruleus, and periaqueductal gray matter (PAG)\] the stimulation mediated by orexin on ventro-lateral part of PAG, and the inhibition on the anti-nociceptive activity in the caudal trigeminal nucleus ([@B5]--[@B7]).

In childhood, the most frequent primary headaches could be considered the migraine without aura (MoA) and tension-type headache with a prevalence of 2--17 and 0.9--24%, respectively ([@B8], [@B9]). Children with migraine headaches appear to have more frequent sleep troubles consisting in insufficient sleep, maternal co-sleeping, longer sleep latency, more bedtime resistance, shorter sleep duration, daytime sleepiness, night awakenings, sleep anxiety, parasomnias, and sleep-disordered breathing compared to children from a normative community sample ([@B10]).

To date, a limited number of polysomnographic studies carried out on patients with migraine, with no conclusive association about any peculiar characteristics of sleep architecture, although migraine attacks seem to be linked to REM stages and associated with a large amount of deep sleep ([@B11]). Moreover, Goder et al. ([@B12]) reported that migraine attacks were preceded by a significant decrease in arousals number, REM density, and in beta power band in the slow wave sleep, and by a decrease in alpha power during the first REM period. However, Vendrame et al. evidenced a high prevalence of sleep fragmentation (i.e., sleep disordered breathing, high rate of awakenings) in children with mild or severe migraine with an increasing related to the severity of symptoms ([@B13], [@B14]). In a PSG study Karthik et al. showed significantly lower sleep efficiency, prolonged sleep onset latency, lesser stage 4 and NREM sleep, and a greater number of total awakenings in migraineurs compared to the controls ([@B15]). In 2016, Nayak et al. showed a decreased REM arousability as well as a decreased overall CAP rate and CAP cycling in adult patients with migraine as compared to controls ([@B16]). In this perspective, we have hypothesized that the sleep parameters (such as macrostructure and microstructure) could be different in children affected by MoA respect of typical developing healthy comparisons (control subjects \[C\]). Therefore, the aim of the present study was to assess the NREM sleep instability in a population of school- aged individuals affected by MoA vs. C.

Materials and Methods {#s2}
=====================

Study Population
----------------

Thirty-three children affected by migraine without aura (MoA) (20 males, 13 females, mean age 10.4 ± 2.0 years) underwent to an overnight PSG recording, after one adaptation night to avoid the first-night effect in the Sleep Laboratory of Child and Adolescent Neuropsychiatry at the Università degli Studi della Campania "Luigi Vanvitelli", Campania Region, Italy. The diagnosis of migraine was made according to international criteria ([@B17]). None of those recruited children had taken prophylactic medication or neither any other regular medication for at least the 2 weeks prior to neither recruitment nor migraine attacks for 48 h at least before the study began.

Following recruitment, to verify the headache characteristics monthly headache frequency and mean headache duration was assessed from daily headache diaries kept by all the children. The headache intensity was assessed on a visual analog (VAS) scale. Exclusion criteria were neurological (i.e., epilepsy, neuromuscular disorders) or psychiatric symptoms (Attention Deficit Hyperactivity Disorder, anxiety, depression, behavior problems), mental retardation (IQ ≤ 70), borderline intellectual functioning (IQ ranging from 71 to 84), and referred signs suggestive for the presence of sleep-related breathing disorders (i.e., habitual snoring, nocturnal apneas), for periodic limb movement disorder (i.e., nocturnal hyperkinesias) and recurrent parasomnias (\>3 episodes per week).

In order to compare the data from MoA children with a control group, 52 healthy children (C) (29 males, 23 females, mean age 9.9 ± 2.4 years) were enrolled from the Campania and Sicily regions schools. The subjects of both groups were recruited from the same urban area, were all of Caucasian origin and had middle socioeconomic status.

The investigation was carried out in accordance with the principles of the Declaration of Helsinki ([@B18]). All adult subjects provided written informed consent and a parent or guardian of any child participant provided written informed consent on their behalf. All procedures were performed in accordance with International guidelines and were approved by Scientific Committee of University of Palermo (n° 2015-001160-19).

Polysomnographic Evaluation (PSG)
---------------------------------

Full overnight PSG recordings were performed according to international criteria ([@B19]--[@B21]), started at the subject\'s usual bedtime and continued until spontaneous morning awakening. The PSG scoring was visually analyzed by means of Hypnolab 1.2 sleep software analysis (SWS Soft, Italy) and the following conventional sleep parameters were evaluated:

1.  Time in bed (TIB);

2.  Sleep period time (SPT);

3.  Total sleep time (TST);

4.  Sleep latency (SL);

5.  First REM latency (FRL);

6.  Number of stage shifts/hour (SS/h); Number of awakenings/hour (AWN/h);

7.  Sleep efficiency (SE%);

8.  Percentage of SPT spent in wakefulness after sleep onset (WASO%);

9.  Percentage of SPT spent in sleep stages 1 (N1%), 2 (N2%), slow-wave sleep (N3%), and REM sleep (REM%).

Moreover, the Arousal Index during the REM sleep was calculated.

About respiratory parameters, central, obstructive and hypopnea events were counted according to the standard criteria ([@B22]) considering as abnormal an Apnea/Hypopnea index (AHI) \>1 ([@B23]). Moreover, periodic limb movements (PLMs) events were identified ([@B24]) and a PLMI≥5 was considered abnormal.

Cyclic Alternating Pattern (CAP) Analysis
-----------------------------------------

CAP was scored following the standard criteria defined by Terzano et al. ([@B25]). CAP A phases have been subdivided into a 3-stage hierarchy of arousal strength: A1 is defined as the A phase with synchronized EEG patterns (intermittent alpha rhythm in stage 1 and sequences of K complexes or delta bursts in the other NREM stages) associated with mild or trivial polygraphic variations; A2 is defined as the A phase with desynchronized EEG patterns preceded by or mixed with slow high-voltage waves (K complexes with alpha and beta activities, K alpha, and arousals with slow-wave synchronization) linked to a moderate increase of muscle tone and/or cardiorespiratory rate; and A3 as the A phase with desynchronized EEG patterns alone (transient activation phases or arousals) or exceeding two thirds of the phase A length and coupled with a remarkable enhancement of muscle tone and/or cardiorespiratory rate ([@B25]).

The following CAP parameters were measured:

-   CAP time (temporal sum of all CAP sequences) in NREM sleep;

-   The CAP rate (percentage of total NREM sleep time occupied by CAP sequences);

-   The number and duration of CAP cycles; the number and duration of CAP sequences;

-   The number, duration, and percentage of A phases (including the phase A subtypes);

-   A1 index (number of A1 phases per hour of NREM sleep);

-   A2 index (number of A2 phases per hour of NREM sleep);

-   A3 index (number of A3 phases per hour of NREM sleep);

-   and the number and duration of B phases.

Statistical Analysis
--------------------

The comparisons between sleep architecture and CAP parameters, obtained in MoA children and typically developing children (C), were carried out by the Mann--Whitney *U* test. Bonferroni correction was applied. *P*-values \<0.01 were considered statistically significant. STATISTICA (data analysis software system), version 6, StatSoft, Inc. (2001) was used for all statistical tests.

Results {#s3}
=======

The two groups (MoA and C) were matched for age, sex, and z-score Body Mass Index (z- BMI) ([Table 1](#T1){ref-type="table"}). The migraine characteristics such as frequency, intensity and duration of attacks were showed in [Table 1](#T1){ref-type="table"}. None of the children with migraine in our series were affected by a migraine attack during the sleep study.

###### 

The comparison between migraine without aura (MoA) and typically developing children (Control) groups in age, sex distribution, and *z*-score Body Mass Index (z-BMI).

                              **MoA**        **Control**   ***p***
  --------------------------- -------------- ------------- ---------
  Age                         10.45 ± 2.06   9.98 ± 2.42   0.355
  Sex (M/F)                   20/13          29/23         0.830
  z-BMI                       0.43 ± 0.51    0.59 ± 0.41   0.115
  Frequency (attacks/month)   9.18 ± 2.84    --            --
  Duration (h)                6.39 ± 2.56    --            --
  Intensity (VAS)             7.45 ± 2.39    --            --

*The frequency, duration, and intensity (assessed with Visuo-analogic Scale, VAS) of migraine attacks were described for MoA group. The t-Test and the Chi-square test, when appropriated, were applied. p values \<0.05 were considered statistically significant*.

As for the macrostructural findings, MoA group showed significant reduction in sleep duration parameters (TIB, SPT, TST; *p* ≤ 0.001 for all) and a significant increase in awakenings per hours (AWK/h) vs. C (*p* = 0.008; [Table 2](#T2){ref-type="table"}). Moreover, the Arousal Index during REM sleep was lower in MoA vs. C children (*p* \< 0.001; [Table 2](#T2){ref-type="table"}).

###### 

Polysomnographic sleep macrostructure findings in MoA and normal control group.

                      **MoA control**   **Mann-Whitney** ***U*****-Test**                                 
  ------------------- ----------------- ----------------------------------- --------- -------- ---------- -------
  TIB-min             473.697           46.459                              588.933   88.132   185.0000   0.000
  SPT-min             446.076           47.033                              557.462   83.305   186.0000   0.000
  TST-min             397.712           70.858                              529.356   78.345   159.0000   0.000
  SOL-min             15.470            13.070                              21.288    17.928   658.5000   NS
  FRL-min             143.727           58.193                              124.423   50.707   695.0000   NS
  SS-h                9.242             2.700                               8.756     3.490    787.5000   NS
  AWN-h               4.088             2.615                               2.137     1.826    472.5000   0.008
  SE%                 83.888            12.056                              90.058    5.205    647.5000   NS
  WASO%               11.058            11.485                              4.910     4.303    620.5000   NS
  N1%                 2.333             2.266                               2.800     3.543    843.0000   NS
  N2%                 36.200            9.286                               43.269    24.558   667.0000   NS
  N3%                 34.015            10.684                              31.194    9.466    759.0000   NS
  REM%                16.361            7.217                               21.200    5.338    526.0000   NS
  AHI                 0.561             0.240                               0.658     0.211    649.0000   NS
  ODI                 0.592             0.174                               0.587     0.148    834.5000   NS
  PLM%                2.970             1.088                               2.748     0.889    769.5000   NS
  REM arousal index   6.606             2.164                               13.269    2.657    44.5000    0.000

*Differences evaluated with the Mann-Whitney-U test, among children affected by migraine without aura (MoA) and control group in the following parameters: TIB, Time in bed (in minutes); SPT, Sleep period time (in minutes); TST, Total sleep time (in minutes); SOL, Sleep onset latency (in minutes); SS/h, Stage shifts per hour; AWN/h, Awakenings per hour; SE%, Sleep efficiency percentage; WASO% percentage, Wakefulness after sleep onset percentage; S1 and S2%, Sleep stages N1 and N2 percentages; N3%, Slow-wave sleep percentage; REM%, Rapid eye movement sleep percentage; AHI, Apnea/Hypopnea Index; ODI, Oxygen Desaturation Index; PLM, Periodic Limb Movements; R arousal Index (REM arousal index). NS means not significant. p values \<0.01 were considered as significant*.

*Bonferroni-corrected value*.

As for the NREM sleep analysis, MoA children showed a reducing in CAP rate% (*p* ≤ 0.001), CAP rate% in N1 (*p* ≤ 0.001) and in CAP rate% in SWS (*p* = 0.004) vs. C. Moreover, the A phases distribution were characterized by significant reduction in slow wave components (Total number CAP A1%, CAP A1 index) (*p* ≤ 0.001) and an increasing in fast components representation (Total number of CAP A2% and CAP A3%) in comparison to C. MoA children show also an increased A1 and A2 mean duration (*p* ≤ 0.001; [Table 3](#T3){ref-type="table"}) in comparison to the healthy control group (C).

###### 

The mean differences, evaluated with the Mann-Whitney-*U* test, among children affected by migraine without aura (MoA) and control group in the following parameters: CAP refers to cyclic alternating pattern; CAP rate (percentage of total NREM sleep time occupied by CAP sequences); percentage and duration of each A phase subtype; A1 index (number of phases A1 per hour of NREM sleep, and of N1, N2, and N3 sleep stage); A2 index (number of phases A2 per hour of NREM sleep, and of N1, N2, and N3 sleep stage); A3 index (number of phases A3 per hour of NREM sleep, and of N1, N2, and N3 sleep stage); duration of B phases; number and duration of CAP sequences.

                   **MoA**            **Control**            **Mann-Whitney**   ***U*-Test**
  ---------------- --------- -------- ------------- -------- ------------------ --------------
  CAP_Rate%        26.539    12.506   34.346        6.496    423.0000           0.001
  CAP_Rate%N1      5.817     18.501   19.877        18.025   256.0000           0.000
  CAP_Rate%N2      21.197    11.414   28.288        10.519   521.5000           NS
  CAP_Rate%N3      35.785    18.298   47.548        7.043    452.0000           0.004
  Tot_num_A1%      47.224    21.804   79.233        11.871   135.5000           0.000
  Tot_num_A2%      36.612    19.302   13.087        12.124   154.0000           0.000
  Tot_num_A3%      16.594    9.725    7.683         3.236    287.0000           0.000
  A1_mean_dur      13.600    4.463    5.312         1.632    39.0000            0.000
  A2_mean_dur      18.079    6.269    8.923         2.632    259.5000           0.000
  A3_mean_dur      13.342    3.714    15.981        6.598    684.5000           NS
  A1_index         14.776    9.607    40.779        10.005   50.0000            0.000
  A2_index         11.521    10.327   7.063         6.324    607.5000           NS
  A3_index         4.288     3.811    3.535         2.943    739.0000           NS
  B_mean_dur       22.715    4.412    22.237        4.066    784.0000           NS
  Cycle_mean_dur   38.024    6.347    28.673        4.881    245.0000           0.000
  Seq_mean_dur     211.852   82.054   202.685       50.890   806.0000           NS
  Num_of_seq       23.939    6.413    39.981        9.407    107.5000           0.000

*p values \<0.01 were considered as significant*.

*NS means not significant*.

*Bonferroni-corrected value*.

Discussion {#s4}
==========

Several reports in the medical literature suggest the existence of a correlation and/or comorbidity between sleep disorders and headache linked to putative common pathophysiological substrates. In general, it has well-known that specific headache disorders, like paroxysmal hemicrania, cluster headache, and hypnic headache may be related to the rapid eye movement sleep (REM) or to obstructive sleep apnea syndrome (OSAS) ([@B4]). The details of the relationship mutual relationship between headache and sleep regulation are not still clearly understood, but it is known that sleep may be related to the occurrence of some headache syndromes while headache could cause or sustain various degrees of sleep disturbance (i.e., parasomnias, sleep disordered breathing, sleep-wake transition disorders). To date, in pediatric populations few studies seem to indicate a suggestive association between headaches and sleep disturbances, including primary snoring, obstructive sleep apnea, and NREM parasomnias although these data are mainly derived from questionnaire-based studies ([@B8], [@B26]--[@B30]).

On the other hand, clinical, and experimental data indicate that the thalamus may be considered as the key structure for migraine pathophysiology. EEG studies have shown that interictal migraine have low thalamo/thalamocortical transmission associated with low brainstem activation ([@B31]). In this picture, we could explain the low arousal index during REM sleep reported in children affected by MoA respect of healthy controls.

Moreover, some reports have showed that children affected by migraine may exhibit disrupted sleep architecture, such as abnormalities in total sleep time (TST) and sleep latency (SOL) compared with healthy control subjects ([@B30]). Conversely, the previous PSG study by Vendrame et al. ([@B13]) showed an important alteration/disruption in sleep in children affected by migraine and chronic migraine linked to the presence of sleep-disordered breathing, shortened TST, and high SOL, even if no healthy controls were used for comparisons.

About these alterations in TST and SOL, the Authors suggested that because some children may find relief from migraine attacks with daytime naps (or the sleep could be useful to stop the attacks), the attacks occurred during the daytime may impact the normal sleep-wake cycle ([@B32]). The severity and frequency of headache attacks may negatively affect sleep architecture provoking sleep disruptions and REM sleep percentages, as confirmed in adult subjects with migraine ([@B33]). Moreover, in adults, the reduction in REM sleep and number of arousals during REM was reported during the night preceding the migraine ([@B34]), and in this perspective a shorter sleep latency during the night before a migraine attack was observed also in children, suggesting a sort of decreasing in cortical activation the night before the onset of headache ([@B35], [@B36]).

Our findings seem to partially confirm some of the results reported previously such as the reduction in TST and SPT, but not in SOL and stages percentages, which in our sample, were not significantly different from healthy controls. As for the sleep disruption, our results seem to confirm the observation that children with migraine tend to show a higher rate of awakenings per hour respect of controls.

As for the NREM sleep instability analysis, the main finding of our study was the reduction in CAP rate percentage and also in N1 and N3. In our population, the CAP A1 representation was reduced in the total number and index, but with a prolonged duration than controls, and the CAP A2 and CAP A3 higher in the total number, and the CAP A2 with a longer duration in MoA vs. C. Our results are substantially in line with the data found in the study conducted in 2016 by Nayak et al. ([@B16]) on a sample of adults with MoA. In their findings the overall CAP rate, the number of CAP cycles and phase B duration was lower among migraineurs while the total phase A and phase 1 duration were increased.

Moreover, our findings confirm the reduction in CAP rate evidenced by Della Marca et al. in adults with frequent MoA ([@B37]). From this point of view, the reduction in oscillatory components during sleep in our sample could be reflecting a general hypoactivity of the arousal systems. Each of these systems has ascending projections to the cortex (which stimulate cortical activation and induce fast EEG activity) and descending projections to the spinal cord (which stimulate motor activation and induce high EMG activity) ([@B38]) and are located within the brainstem, the thalamus, the hypothalamus, and the basal forebrain ([@B39]). These areas could be considered actually as the generators of the migraine attacks ([@B40], [@B41]).

In our sample the CAP reduction involved prevalently the A1 phases subtypes, less so the high-frequency EEG arousals. One main role of CAP A1 fluctuations is to buffer the effect of perturbations occurring during NREM sleep ([@B37]). It can therefore be speculated that the reduction of CAP expresses a reduced efficacy of such mechanisms of processing of incoming inputs during sleep in migraine. Finally, we have to consider that to the best our knowledge, this is the first attempt to evaluate NREM instability and CAP parameters in children affected by migraine without aura compared with a control group.

In conclusion, the reduction of arousability and lower NREM sleep instability seem to be associated with MoA in children. These findings may have clinical implications. However, further studies are needed for a better comprehension of the pathophysiological mechanisms underlying the link between migraine and NREM sleep and to investigate possible consequent clinical implications and preventive treatments.
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